Status:
UNKNOWN
Handwriting Analysis in Movement Disorders
Lead Sponsor:
Neuromed IRCCS
Conditions:
Movement Disorders
Parkinson Disease
Eligibility:
All Genders
18-90 years
Brief Summary
Handwriting is a complex cognitive prowess that deteriorates in patients affected by neurodegenerative diseases, including movement disorders. More in detail, patients with Parkinson's disease (PD) ma...
Eligibility Criteria
Inclusion
- Healthy conditions
- clinical diagnosis of Parkinson's disease
Exclusion
- cognitive decline
Key Trial Info
Start Date :
December 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT05355480
Start Date
December 1 2022
End Date
December 31 2023
Last Update
March 23 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS Neuromed
Pozzilli, Italy, 86077